HARRISBURG, Pa., May 30, 2017 /PRNewswire/ -- Can Prebiotin play a role in managing and possibly preventing an illness that affects more than 500,000 Americans every year, with more than 29,000 related deaths? Yes, says Dr. Wilson Jackson, Prebiotin prebiotic fiber medical director, in an interview for the Peggy Lillis Foundation (PLF). The foundation has been building a nationwide clostridium difficile (C. diff) awareness movement by educating the public, empowering advocates, and shaping policy since it was founded in 2010.
Christian John Lillis, PLF's executive director, interviewed Dr. Wilson Jackson, a gastroenterologist and son of Prebiotin founder, Frank W. Jackson, MD, on the growth and management of microbiome-related illnesses like C. diff. "Dysbiosis is the term applied to the unfavorable population of bacteria that may adversely affect a person's health," says Jackson. "We have over 600 different species of bacteria in our gut, and C. diff is one them, but it's normally kept in check by the other bacteria. Antibiotic use can throw the whole balance off."
Peggy Lillis, the mother of PLF co-founders Christian and Liam Lillis, died from a C. diff infection after antibiotics prophylaxis following a dental procedure in 2010. "Most cases of C. diff infection, including our mother Peggy's, are precipitated by using antibiotics, which often deplete the good gut bacteria along with the bad. This dysbiosis allows infections like C. diff to take over. That's why we share Prebiotin's deep belief that a healthy gut microbiome is a vital part of good health," says Christian John Lillis.
During the interview for the blog, Jackson explains that according to research studies, Prebiotin, oligofructose-enriched inulin (OEI), is able to help a better microflora take root. With the product's ability to nourish the desirable bacteria in the colon, Jackson uses the prebiotic fiber before, during, and after Fecal Microbial Transplantation (FMT), which has a 90% + cure rate for C. diff in his practice.
"Our protocol is to place a patient on Prebiotin prior to the FMT, then at least three weeks following the procedure. We also add Prebiotin to the FMT slurry at the time of the transplant. …We advise staying on Prebiotin to reduce the likelihood of C. diff recurring," says Jackson, who notes that FMT also shows promise of helping patients with ulcerative colitis and Crohn's colitis.
Jackson concludes, "We are at the beginning of what may prove a revolution in disease and health management. Better understanding of the interplay between the microbiome and our health will enable us to educate the medical community and impact patient care."
The Peggy Lillis Foundation shares Jackson's emphasis on developing a better understanding of the microbiome. On April 27, 2017, 60 leaders and advocates attended the foundation's second Advocates Summit & National Strategy Meeting in New York City, with presentations from experts in the fields of medicine, public health, activism, microbiology, and others. For more information, visit the Peggy Lillis Foundation website.
Prebiotin is currently involved in two NIH studies and several others with leading research universities and Health Canada. Studies using natural supplements have been and still are rare. "Most studies involving structure-function health claims or disease categories are with drugs, which is why Prebiotin is proud to be included in so many reputable studies," says Prebiotin CEO, Ron Walborn Jr.
Jackson GI Medical/Prebiotin was founded by visionary prebiotic pioneer Dr. Frank Jackson in 2008, and is dedicated to the responsible development and marketing of medically credible nutritional supplements backed by third-party research. Located in Harrisburg, PA, the company can be reached at 855-466-3488 or online at http://www.prebiotin.com.
* Disclaimer: Prebiotin helped sponsor the Peggy Lilli Foundation 2016 Gala; however, this relationship and interview does not constitute an endorsement of Prebiotin prebiotic fiber by the PLF, its staff, or board of directors.
Contact: Anne Mercer Larson
Prebiotin Director of Marketing and Public Relations
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/prebiotin-medical-director-interviewed-by-peggy-lillis-foundation-executive-director-on-the-role-of-prebiotin-in-managing-c-diff-300464587.html